WuXi Vaccines is a subsidiary of WuXi Biologics focused on vaccine and prophylactic antibody development and manufacturing. The company operates as a Contract Development and Manufacturing Organization (CDMO), supporting pharmaceutical and biotechnology companies with end-to-end services spanning process development, analytical testing, GMP manufacturing, and commercial supply.

Founded in 2018, the company leverages WuXi Biologics’ global manufacturing network and technical infrastructure to support a broad range of vaccine modalities, including recombinant proteins, viral vaccines, viral-vectored vaccines, VLPs, nucleic acid vaccines, and conjugated vaccines. WuXi Vaccines operates facilities and development capabilities across China, Singapore, Ireland, Europe, and other global locations to provide integrated development and manufacturing solutions.

The company supports customers from early-stage development through commercial manufacturing using mammalian, microbial, and viral production systems. Its facilities include drug substance manufacturing, drug product manufacturing, fill-finish operations, quality control laboratories, and process development capabilities designed to support global regulatory compliance and large-scale vaccine supply.

WuXi Vaccines has supported multiple commercial vaccine and prophylactic antibody programmes globally and has delivered hundreds of millions of doses through GMP-certified manufacturing facilities. The company positions itself as a specialist vaccine CDMO focused on accelerating access to preventive healthcare products worldwide.

Key Products and Services
Vaccine process development
Prophylactic antibody development and manufacturing
Drug substance (DS) manufacturing
Drug product (DP) manufacturing and fill-finish services
GMP manufacturing for clinical and commercial supply
Analytical testing and quality control
Cell line and upstream/downstream process development
Mammalian, microbial, and viral production systems
Technology transfer and scale-up support
Regulatory and CMC support services
Commercial vaccine manufacturing
Integrated end-to-end CDMO services for vaccine developers

With a dedicated focus on vaccines and prophylactic antibodies, WuXi Vaccines has built an integrated global CDMO platform designed to support partners from early development through commercial manufacturing. Through its combination of global manufacturing infrastructure, regulatory expertise, and multi-modality vaccine capabilities, the company supports pharmaceutical and biotechnology organisations developing preventive therapies for international markets.